Skip to content

Dogwood Therapeutics, Inc.

DWTX Nasdaq SEC CIK 1818844

Follow Dogwood Therapeutics Weekly email: filings, results, news

News

2 stories filed under Dogwood Therapeutics

Markets

Thread · 2 stories

H.C. Wainwright reiterates Dogwood Therapeutics stock rating at buy

Markets 21 d ago 3 sources

Dogwood Therapeutics, Inc. (DWTX) Discusses Halneuron and Pipeline Advances for Chemotherapy-Induced Neuropathic Pain Transcript

Markets 22 d ago

Profile

Headquarters: ALPHARETTA, GA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator